Christine Mikail Cvijic, President and CFO at Neurogene Inc. (NGNE), sold 9,600 shares at $30.07 ($300K) on 2026-05-06, disclosed to the SEC on 2026-05-08.
Scheduled sale ($300k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.07 | 4,800 | $144K | 48.1% |
| 2 | $32.44 | 4,800 | $156K | 51.9% |
| Total | $31.25 avg | 9,600 | $300K | 100% |
| Filing → |
| NGNE | SELL | 2026-03-30 | $111K | — | Filing → |
| NGNE | SELL | 2026-03-17 | $168K | — | Filing → |
| NGNE | SELL | 2026-03-03 | $121K | — | Filing → |